Compare Stocks Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare ShareLink copied to clipboard. NASDAQ:ALFIWNYSE:BTXNASDAQ:CIDMNASDAQ:NLOK Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALFIWAlfi$0.00$0.00$0.00▼$2.88N/AN/A6,051 shsN/ABTXBrooklyn ImmunoTherapeutics$1.10$1.33$0.17▼$10.10$64.71M4.61515,543 shs172,070 shsCIDMCinedigm$2.47-2.0%$1.20$0.27▼$0.79$461.68M2.05710,288 shs141,524 shsNLOKNortonLifeLock$26.91-0.7%$26.83$20.12▼$30.92$15.38B0.765.78 million shs3.18 million shs7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALFIWAlfi0.00%0.00%-99.49%0.00%0.00%BTXBrooklyn ImmunoTherapeutics+7.32%+20.88%-4.35%-39.23%-21.98%CIDMCinedigm+11.75%+18.87%+157.41%+211.11%+149.50%NLOKNortonLifeLock+0.30%0.00%-1.17%+4.31%+62.82%top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALFIWAlfiN/AN/AN/AN/AN/AN/AN/AN/ABTXBrooklyn ImmunoTherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ACIDMCinedigmN/AN/AN/AN/AN/AN/AN/AN/ANLOKNortonLifeLock1.0284 of 5 stars0.00.01.73.60.61.70.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALFIWAlfiN/AN/AN/AN/ABTXBrooklyn ImmunoTherapeuticsN/AN/AN/AN/ACIDMCinedigmN/AN/AN/AN/ANLOKNortonLifeLockN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALFIWAlfi$200.68KN/AN/AN/AN/AN/ABTXBrooklyn ImmunoTherapeuticsN/AN/AN/AN/AN/AN/ACIDMCinedigm$72.33M6.38N/AN/AN/A∞NLOKNortonLifeLock$2.82B5.46N/AN/AN/A∞Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALFIWAlfiN/AN/A0.00∞N/AN/AN/AN/AN/ABTXBrooklyn ImmunoTherapeuticsN/A-$2.27N/A∞N/AN/AN/AN/AN/ACIDMCinedigmN/A-$0.05N/A∞N/AN/AN/AN/AN/ANLOKNortonLifeLockN/A$1.4318.82∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALFIWAlfiN/AN/AN/AN/AN/ABTXBrooklyn ImmunoTherapeuticsN/AN/AN/AN/AN/ACIDMCinedigmN/AN/AN/AN/AN/ANLOKNortonLifeLock$0.501.86%+44.22%34.97%N/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipALFIWAlfiN/ABTXBrooklyn ImmunoTherapeutics26.00%CIDMCinedigm8.03%NLOKNortonLifeLock94.86%Insider OwnershipCompanyInsider OwnershipALFIWAlfiN/ABTXBrooklyn ImmunoTherapeutics20.50%CIDMCinedigm16.40%NLOKNortonLifeLock3.30%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableALFIWAlfi40N/AN/ANot OptionableBTXBrooklyn ImmunoTherapeuticsN/A58.83 millionN/ANo DataCIDMCinedigm140186.92 millionN/ANot OptionableNLOKNortonLifeLockN/A571.37 millionN/AOptionableBTX, CIDM, ALFIW, and NLOK HeadlinesRecent News About These CompaniesStockNews.com Initiates Coverage on NortonLifeLock (NASDAQ:NLOK)October 30 at 2:07 AM | americanbankingnews.comNortonLifeLock (NASDAQ:NLOK) Now Covered by StockNews.comOctober 21, 2024 | americanbankingnews.comGen Digital Inc. (NLOK.VI)August 30, 2024 | finance.yahoo.comGen Digital Inc 1NLOKJuly 25, 2024 | morningstar.comGen Digital (GEN) Earnings Dates & ReportsAugust 4, 2023 | investing.comTime to question our dividend-based stock screenAugust 1, 2023 | investorschronicle.co.ukGen Digital (NASDAQ: GEN)July 8, 2023 | fool.comGen Digital (GEN) Beats on Q4 Earnings and Revenue EstimatesMay 12, 2023 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAlfiNASDAQ:ALFIWAlfi, Inc. provides interactive intelligent artificial intelligence and machine learning software solutions. Alfi, Inc. was formerly known as Lectrefy, Inc. and changed its name to Alfi, Inc. in January 2020. The company was founded in 2018 and is based in Miami Beach, Florida.Brooklyn ImmunoTherapeuticsNYSE:BTXEterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.CinedigmNASDAQ:CIDMCineverse Corp. is a global streaming technology and entertainment company. It owns and operates streaming channels, all powered by its advanced, proprietary technology platform. The firm currently features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. It entertains consumers around the globe by providing premium feature films and television series, enthusiast streaming channels, and technology services to some media, retail, and technology companies. The company was founded by A. Dale Mayo on March 31, 2000 and is headquartered in New York, NY.NortonLifeLockNASDAQ:NLOKGen Digital, Inc. engages in the provision of security, storage, and systems management solutions. The firm focuses on providing consumer cyber safety with its business solutions. The company was founded by Gary Hendrix in April 1982 and is headquartered in Tempe, AZ. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.